Regression of Atherosclerosis Is Characterized by Broad Changes in the Plaque Macrophage Transcriptome
Author(s) -
Jonathan E. Feig,
Yuliya Vengrenyuk,
Vladimı́r Reiser,
Chaowei Wu,
Alexander Statnikov,
Constantin Aliferis,
Michael J. Garabedian,
Edward A. Fisher,
Óscar Puig
Publication year - 2012
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0039790
Subject(s) - cd68 , cd163 , macrophage , transcriptome , biology , inflammation , monocyte , vinculin , foam cell , microbiology and biotechnology , gene expression , cell adhesion , m2 macrophage , phenotype , transdifferentiation , pathology , gene , immunology , cell , medicine , immunohistochemistry , stem cell , genetics , in vitro
We have developed a mouse model of atherosclerotic plaque regression in which an atherosclerotic aortic arch from a hyperlipidemic donor is transplanted into a normolipidemic recipient, resulting in rapid elimination of cholesterol and monocyte-derived macrophage cells (CD68+) from transplanted vessel walls. To gain a comprehensive view of the differences in gene expression patterns in macrophages associated with regressing compared with progressing atherosclerotic plaque, we compared mRNA expression patterns in CD68+ macrophages extracted from plaque in aortic aches transplanted into normolipidemic or into hyperlipidemic recipients. In CD68+ cells from regressing plaque we observed that genes associated with the contractile apparatus responsible for cellular movement (e.g. actin and myosin) were up-regulated whereas genes related to cell adhesion (e.g. cadherins, vinculin) were down-regulated. In addition, CD68+ cells from regressing plaque were characterized by enhanced expression of genes associated with an anti-inflammatory M2 macrophage phenotype, including arginase I, CD163 and the C-lectin receptor. Our analysis suggests that in regressing plaque CD68+ cells preferentially express genes that reduce cellular adhesion, enhance cellular motility, and overall act to suppress inflammation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom